Jasper Historical Cash Flow

JSPR Stock  USD 22.31  0.09  0.40%   
Analysis of Jasper Therapeutics cash flow over time is an excellent tool to project Jasper Therapeutics future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Stock Based Compensation of 5.5 M or Change In Working Capital of 5.4 M as it is a great indicator of Jasper Therapeutics ability to facilitate future growth, repay debt on time or pay out dividends.
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Jasper Therapeutics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Jasper Therapeutics is a good buy for the upcoming year.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Jasper Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
To learn how to invest in Jasper Stock, please use our How to Invest in Jasper Therapeutics guide.

About Jasper Cash Flow Analysis

The Cash Flow Statement is a financial statement that shows how changes in Jasper balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Jasper's non-liquid assets can be easily converted into cash.

Jasper Therapeutics Cash Flow Chart

At this time, Jasper Therapeutics' Change In Cash is relatively stable compared to the past year. As of 12/12/2024, Stock Based Compensation is likely to grow to about 5.5 M, while Begin Period Cash Flow is likely to drop slightly above 37.6 M.

Net Borrowings

The difference between the amount of new debt a company has taken on and the amount of debt it has paid off during a given period.

Stock Based Compensation

Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.

Begin Period Cash Flow

The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.

Capital Expenditures

Capital Expenditures are funds used by Jasper Therapeutics to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Jasper Therapeutics operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.
Most accounts from Jasper Therapeutics' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Jasper Therapeutics current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Jasper Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
To learn how to invest in Jasper Stock, please use our How to Invest in Jasper Therapeutics guide.At this time, Jasper Therapeutics' Change In Cash is relatively stable compared to the past year. As of 12/12/2024, Stock Based Compensation is likely to grow to about 5.5 M, while Begin Period Cash Flow is likely to drop slightly above 37.6 M.
 2023 2024 (projected)
Stock Based Compensation5.2M5.5M
Net Borrowings64.8K61.6K

Jasper Therapeutics cash flow statement Correlations

0.09-0.040.00.65-0.5-0.090.140.090.81-0.43-0.080.50.070.480.43-0.43-0.220.09-0.120.19
0.09-0.820.93-0.38-0.83-0.450.310.710.320.180.91-0.690.55-0.290.230.35-0.670.71-0.710.71
-0.04-0.82-0.950.620.830.78-0.31-0.98-0.330.29-0.960.66-0.88-0.06-0.660.040.91-0.980.98-0.97
0.00.93-0.95-0.51-0.86-0.720.460.890.370.010.96-0.80.81-0.240.410.26-0.850.89-0.890.88
0.65-0.380.62-0.510.080.370.25-0.580.520.16-0.670.6-0.45-0.03-0.320.040.42-0.580.56-0.48
-0.5-0.830.83-0.860.080.68-0.55-0.81-0.760.18-0.770.44-0.750.01-0.54-0.050.84-0.810.82-0.86
-0.09-0.450.78-0.720.370.68-0.57-0.86-0.490.39-0.640.61-0.94-0.07-0.650.110.94-0.860.86-0.88
0.140.31-0.310.460.25-0.55-0.570.350.690.250.21-0.460.58-0.53-0.030.49-0.420.35-0.370.42
0.090.71-0.980.89-0.58-0.81-0.860.350.39-0.430.89-0.590.940.160.76-0.16-0.941.0-1.00.99
0.810.32-0.330.370.52-0.76-0.490.690.39-0.230.170.030.490.090.39-0.08-0.510.39-0.420.49
-0.430.180.290.010.160.180.390.25-0.43-0.23-0.08-0.38-0.39-0.93-0.910.950.41-0.430.43-0.43
-0.080.91-0.960.96-0.67-0.77-0.640.210.890.17-0.08-0.750.74-0.10.470.13-0.820.89-0.880.86
0.5-0.690.66-0.80.60.440.61-0.46-0.590.03-0.38-0.75-0.590.60.03-0.590.59-0.590.58-0.56
0.070.55-0.880.81-0.45-0.75-0.940.580.940.49-0.390.74-0.590.060.69-0.09-0.920.94-0.950.95
0.48-0.29-0.06-0.24-0.030.01-0.07-0.530.160.09-0.93-0.10.60.060.76-0.99-0.160.16-0.160.16
0.430.23-0.660.41-0.32-0.54-0.65-0.030.760.39-0.910.470.030.690.76-0.76-0.740.76-0.760.76
-0.430.350.040.260.04-0.050.110.49-0.16-0.080.950.13-0.59-0.09-0.99-0.760.16-0.160.16-0.16
-0.22-0.670.91-0.850.420.840.94-0.42-0.94-0.510.41-0.820.59-0.92-0.16-0.740.16-0.950.95-0.96
0.090.71-0.980.89-0.58-0.81-0.860.351.00.39-0.430.89-0.590.940.160.76-0.16-0.95-1.00.99
-0.12-0.710.98-0.890.560.820.86-0.37-1.0-0.420.43-0.880.58-0.95-0.16-0.760.160.95-1.0-1.0
0.190.71-0.970.88-0.48-0.86-0.880.420.990.49-0.430.86-0.560.950.160.76-0.16-0.960.99-1.0
Click cells to compare fundamentals

Jasper Therapeutics Account Relationship Matchups

Pair Trading with Jasper Therapeutics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Jasper Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Jasper Therapeutics will appreciate offsetting losses from the drop in the long position's value.

Moving against Jasper Stock

  0.72IMAB I MabPairCorr
  0.51GNFT GenfitPairCorr
  0.47LLY Eli LillyPairCorr
  0.47PFE Pfizer Inc Fiscal Year End 4th of February 2025 PairCorr
  0.4FLGC Flora Growth CorpPairCorr
The ability to find closely correlated positions to Jasper Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Jasper Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Jasper Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Jasper Therapeutics to buy it.
The correlation of Jasper Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Jasper Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Jasper Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Jasper Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for Jasper Stock Analysis

When running Jasper Therapeutics' price analysis, check to measure Jasper Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jasper Therapeutics is operating at the current time. Most of Jasper Therapeutics' value examination focuses on studying past and present price action to predict the probability of Jasper Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jasper Therapeutics' price. Additionally, you may evaluate how the addition of Jasper Therapeutics to your portfolios can decrease your overall portfolio volatility.